Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Aspira Women's Health Inc. (AWHL) vs DermTech, Inc. (DMTKQ)

Aspira Women's Health Inc. and DermTech, Inc. are both Diagnostics & Research companies. DermTech, Inc. is the larger, with a market value of $3.3M against $2.4M — 1.3× the size. DermTech, Inc. grew revenue faster over the last twelve months: 9.71% against −8.00%. Aspira Women's Health Inc. has the higher net margin (−117.1% vs −572.2%) and the higher return on invested capital (0.00% vs −5,493.5%). Across the 16 metrics below, Aspira Women's Health Inc. leads on 9 and DermTech, Inc. on 7.

Valuation

Metric AWHL DMTKQ Diagnostics & Research median
P/E n/m n/m 33.95
P/S 1.35 n/m 4.87
P/B n/m n/m 3.12
Price to free cash flow n/m n/m 34.02
EV/EBITDA n/m 0.45 25.20
EV/Sales 1.52 (2.49) 5.66
Earnings yield (93.85%) 0.00% (1.75%)
Free cash flow yield (41.10%) 0.00% (0.13%)

Profitability

Metric AWHL DMTKQ Diagnostics & Research median
Gross margin 58.78% 8.51% 50.89%
Operating margin (80.75%) (588.62%) (8.57%)
Net margin (117.07%) (572.19%) (6.37%)
Free cash flow margin (55.32%) (460.10%) 0.00%
Return on equity 201.29% (121.75%) (2.92%)
Return on assets (213.58%) (64.00%) (6.71%)
Return on invested capital 0.00% (5,493.45%) 0.00%

Growth

Metric AWHL DMTKQ Diagnostics & Research median
Revenue growth (TTM) (8.00%) 9.71% 7.69%
EPS growth (last fiscal year) 60.22% 20.36% —
Revenue growth, 5-year CAGR 14.66% 44.33% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AWHL DMTKQ Diagnostics & Research median
Debt to equity (0.27) 0.00 0.11
Current ratio 0.52 3.53 2.02
Net debt to EBITDA 0.00 0.57 0.78

Dividend

Metric AWHL DMTKQ Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric AWHL DMTKQ Diagnostics & Research median
Market cap 2.44m 3.29m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack